Hema Now: The Future of Lymphoma Care – Part 2 - European Medical Journal

This site is intended for healthcare professionals

Hema Now: The Future of Lymphoma Care – Part 2

Hematology

Hema Now

In this episode of Hema Now, we sit down with Toby Eyre, Consultant Haematologist at Oxford University Hospitals, to explore the latest advances in lymphoma and CLL, discuss unanswered questions in mantle cell lymphoma, and consider how emerging research is shaping the future of lymphoma care.

 

Toby Eyre

 

Toby Eyre is a Consultant Haematologist at Oxford University Hospitals NHS Foundation Trust, specialising in the management of lymphoid malignancies, including lymphoma and chronic lymphocytic leukaemia. His research interests include clinical trials, novel targeted therapies, biomarkers and the management of complex lymphoid malignancies.

 

Timestamps:    

00:00 – Distinguishing practice-changing data from early findings

01:38 – Research achievements and patient impact

04:38 – Raising awareness of blood cancers

08:45 – Advice for early-career haematologists

10:20 – Three wishes for future care

Disclaimer: The opinions expressed in this episode belong to the speakers and do not necessarily represent the opinions of EMJ.

Rate this content's potential impact on patient outcomes

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this content.